ACM
AMRX icon

Accent Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Accent Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Buy
+1,965
New +$26.9K 0.01% 128
2026
Q1 		– Sell
-600
Closed -$7.56K – 338
2025
Q4 		$7.56K Buy
+600
New +$6.87K ﹤0.01% 232

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Accent Capital Management's AMRX Position: Q2 2026 in Review

Accent Capital Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 1,965 shares worth $34K. The stake represents 0.01% of the portfolio and ranks #128 among its holdings. This is a return to the name: Accent Capital Management previously reported a position in AMRX as recently as Q4 2025.

Accent Capital Management first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Accent Capital Management held 1,965 shares of Amneal Pharmaceuticals worth $34K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Accent Capital Management position in Q2 2026.
  • Amneal Pharmaceuticals made up 0.01% of Accent Capital Management's portfolio in Q2 2026, its #128 holding.
  • Accent Capital Management first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Accent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.